Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03029143
Brief Title: Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis (ENTERPRET)

First Submitted : January 20, 2017
First Submitted that Met QC Criteria : January 20, 2017
First Posted : January 24, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : August 13, 2019
Last Update Posted : August 14, 2019